Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001628280-23-003159
Filing Date
2023-02-10
Accepted
2023-02-10 16:01:02
Documents
17

Document Format Files

Seq Description Document Type Size
1 424B4 mineralys-424b4.htm 424B4 2117578
2 backcoverlogo.jpg GRAPHIC 21702
3 business11e.jpg GRAPHIC 662846
4 business12b.jpg GRAPHIC 270397
5 business13d.jpg GRAPHIC 552652
6 business2e.jpg GRAPHIC 537942
7 business3b.jpg GRAPHIC 671014
8 business4b.jpg GRAPHIC 386220
9 business5c.jpg GRAPHIC 1637794
10 business6b.jpg GRAPHIC 148220
11 business7e.jpg GRAPHIC 1449669
12 business8d.jpg GRAPHIC 393695
13 business9c.jpg GRAPHIC 631115
14 busniess10d.jpg GRAPHIC 616213
15 mineralyslogo.jpg GRAPHIC 34244
16 mineralyslogoa.jpg GRAPHIC 30240
17 prospectussummary1b.jpg GRAPHIC 196658
  Complete submission text file 0001628280-23-003159.txt   13120956
Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Filer) CIK: 0001933414 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-269282 | Film No.: 23611659
SIC: 2834 Pharmaceutical Preparations